rs869320695
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The ENST00000308159.10(NUP93):c.1326del(p.Lys442AsnfsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
NUP93
ENST00000308159.10 frameshift
ENST00000308159.10 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.349
Genes affected
NUP93 (HGNC:28958): (nucleoporin 93) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. This gene encodes a nucleoporin protein that localizes both to the basket of the pore and to the nuclear entry of the central gated channel of the pore. The encoded protein is a target of caspase cysteine proteases that play a central role in programmed cell death by apoptosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-56832368-AG-A is Pathogenic according to our data. Variant chr16-56832368-AG-A is described in ClinVar as [Pathogenic]. Clinvar id is 224966.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-56832368-AG-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUP93 | NM_014669.5 | c.1326del | p.Lys442AsnfsTer14 | frameshift_variant | 12/22 | ENST00000308159.10 | NP_055484.3 | |
NUP93 | NM_001242795.2 | c.957del | p.Lys319AsnfsTer14 | frameshift_variant | 10/20 | NP_001229724.1 | ||
NUP93 | NM_001242796.2 | c.957del | p.Lys319AsnfsTer14 | frameshift_variant | 10/20 | NP_001229725.1 | ||
NUP93 | XM_005256263.4 | c.1326del | p.Lys442AsnfsTer14 | frameshift_variant | 12/22 | XP_005256320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP93 | ENST00000308159.10 | c.1326del | p.Lys442AsnfsTer14 | frameshift_variant | 12/22 | 1 | NM_014669.5 | ENSP00000310668 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Nephrotic syndrome, type 12 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 20, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at